nodes	percent_of_prediction	percent_of_DWPC	metapath
Propericiazine—Dental caries—Riluzole—amyotrophic lateral sclerosis	0.0865	0.091	CcSEcCtD
Propericiazine—Traumatic liver injury—Riluzole—amyotrophic lateral sclerosis	0.0865	0.091	CcSEcCtD
Propericiazine—Priapism—Riluzole—amyotrophic lateral sclerosis	0.0667	0.0701	CcSEcCtD
Propericiazine—Respiratory depression—Riluzole—amyotrophic lateral sclerosis	0.0428	0.045	CcSEcCtD
Propericiazine—Glaucoma—Riluzole—amyotrophic lateral sclerosis	0.0428	0.045	CcSEcCtD
Propericiazine—Pulmonary function test decreased—Riluzole—amyotrophic lateral sclerosis	0.0428	0.045	CcSEcCtD
Propericiazine—Liver injury—Riluzole—amyotrophic lateral sclerosis	0.0383	0.0403	CcSEcCtD
Propericiazine—Amenorrhoea—Riluzole—amyotrophic lateral sclerosis	0.0367	0.0386	CcSEcCtD
Propericiazine—Ventricular tachycardia—Riluzole—amyotrophic lateral sclerosis	0.0322	0.0339	CcSEcCtD
Propericiazine—Pulmonary embolism—Riluzole—amyotrophic lateral sclerosis	0.0322	0.0339	CcSEcCtD
Propericiazine—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.0266	0.028	CcSEcCtD
Propericiazine—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.0249	0.0262	CcSEcCtD
Propericiazine—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.0213	0.0224	CcSEcCtD
Propericiazine—Asthma—Riluzole—amyotrophic lateral sclerosis	0.0202	0.0213	CcSEcCtD
Propericiazine—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.0186	0.0196	CcSEcCtD
Propericiazine—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.0185	0.0194	CcSEcCtD
Propericiazine—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.0184	0.0193	CcSEcCtD
Propericiazine—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.0181	0.0191	CcSEcCtD
Propericiazine—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.0176	0.0185	CcSEcCtD
Propericiazine—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.0168	0.0177	CcSEcCtD
Propericiazine—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.015	0.0158	CcSEcCtD
Propericiazine—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.0145	0.0152	CcSEcCtD
Propericiazine—Tremor—Riluzole—amyotrophic lateral sclerosis	0.0132	0.0139	CcSEcCtD
Propericiazine—Agitation—Riluzole—amyotrophic lateral sclerosis	0.0129	0.0136	CcSEcCtD
Propericiazine—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.0129	0.0135	CcSEcCtD
Propericiazine—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.0117	0.0123	CcSEcCtD
Propericiazine—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.0116	0.0122	CcSEcCtD
Propericiazine—Oedema—Riluzole—amyotrophic lateral sclerosis	0.0115	0.0121	CcSEcCtD
Propericiazine—Infection—Riluzole—amyotrophic lateral sclerosis	0.0114	0.012	CcSEcCtD
Propericiazine—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.0112	0.0118	CcSEcCtD
Propericiazine—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.0111	0.0117	CcSEcCtD
Propericiazine—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.0107	0.0113	CcSEcCtD
Propericiazine—DRD1—nerve—amyotrophic lateral sclerosis	0.0105	0.255	CbGeAlD
Propericiazine—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.0104	0.0109	CcSEcCtD
Propericiazine—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.0102	0.0108	CcSEcCtD
Propericiazine—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.0102	0.0107	CcSEcCtD
Propericiazine—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00983	0.0103	CcSEcCtD
Propericiazine—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00909	0.00956	CcSEcCtD
Propericiazine—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00847	0.00891	CcSEcCtD
Propericiazine—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00787	0.00827	CcSEcCtD
Propericiazine—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00731	0.00769	CcSEcCtD
Propericiazine—Rash—Riluzole—amyotrophic lateral sclerosis	0.00725	0.00762	CcSEcCtD
Propericiazine—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00724	0.00761	CcSEcCtD
Propericiazine—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00683	0.00718	CcSEcCtD
Propericiazine—ADRA2A—peripheral nervous system—amyotrophic lateral sclerosis	0.00618	0.15	CbGeAlD
Propericiazine—Trifluoperazine—SIGMAR1—amyotrophic lateral sclerosis	0.0051	0.651	CrCbGaD
Propericiazine—DRD1—brainstem—amyotrophic lateral sclerosis	0.00451	0.109	CbGeAlD
Propericiazine—Clomipramine—GSTP1—amyotrophic lateral sclerosis	0.00273	0.349	CrCbGaD
Propericiazine—ADRA1B—nervous system—amyotrophic lateral sclerosis	0.00253	0.0615	CbGeAlD
Propericiazine—ADRA1B—central nervous system—amyotrophic lateral sclerosis	0.00244	0.0592	CbGeAlD
Propericiazine—DRD1—nervous system—amyotrophic lateral sclerosis	0.00236	0.0573	CbGeAlD
Propericiazine—DRD1—central nervous system—amyotrophic lateral sclerosis	0.00227	0.0552	CbGeAlD
Propericiazine—ADRA1B—brain—amyotrophic lateral sclerosis	0.00194	0.047	CbGeAlD
Propericiazine—DRD1—brain—amyotrophic lateral sclerosis	0.00181	0.0438	CbGeAlD
Propericiazine—ADRA2A—medulla oblongata—amyotrophic lateral sclerosis	0.00144	0.0349	CbGeAlD
Propericiazine—ADRA2A—spinal cord—amyotrophic lateral sclerosis	0.00129	0.0312	CbGeAlD
Propericiazine—ADRA2A—nervous system—amyotrophic lateral sclerosis	0.00108	0.0263	CbGeAlD
Propericiazine—ADRA2A—central nervous system—amyotrophic lateral sclerosis	0.00104	0.0253	CbGeAlD
Propericiazine—ADRA2A—cerebellum—amyotrophic lateral sclerosis	0.00102	0.0247	CbGeAlD
Propericiazine—ADRA2A—brain—amyotrophic lateral sclerosis	0.000828	0.0201	CbGeAlD
